SUN-168 Diagnosis of 46,XY Differences in Sex Development in a Patient with Adrenocortical Carcinoma

Abstract Disclosure: K. Baez: None. M. Aoun: None. I. Blanco: None. R.R. Savian: None. A. Razzeto: None. C.V. Villabona: None. 61-year-old patient with a history of adrenocortical carcinoma, leading to ACTH - independent Cushing syndrome s/p adrenalectomy, hypertension, fatty liver, hyperlipidemia, and asthma, presented for follow-up in the outpatient endocrinology clinic. The patient was incidentally found to have a large left adrenal mass in 2016 on a CT scan performed for symptoms of pyelonephritis. Laboratory evaluation revealed hypercortisolism and hyperandrogenemia with normal metanephrines and normetanephrines. The patient underwent left laparoscopic adrenalectomy in 2018, she was found to have an adrenocortical carcinoma. She underwent radiation therapy, and received mitotane treatment for two years along with hydrocortisone replacement therapy. She has primary adrenal insufficiency treated with hydrocortisone and fludrocortisone. The patient, on review of systems, reported a history of primary amenorrhea and delayed development of secondary sexual characteristics —absent terminal hair in the axilla and pubis. As a child she reported she had multiple tests and she underwent a surgical intervention to dilate the vaginal canal but she has been unaware of her condition. An evaluation in her teenage years revealed an absence of ovaries and uterus. The patient was started on estrogen replacement therapy, which she took late teen years until her early 20s. She reported difficulties having sexual intercourse. Additionally, on family history she reported her parents were first cousins and the patient has color blindness, this detail on her history ( X-linked recessive inheritance pattern disorder ) let us suspect she had a 46 XY karyotype. On laboratory tests, besides having adrenal insufficiency her estradiol and testosterone levels were low with high gonadotropins. Chromosomal analysis revealed a 46,XY karyotype without mosaicism, as we suspected. Conclusion: We report a rare case and first case described in the literature of a patient with gonadal dysgenesis with an adrenocortical carcinoma causing Cushing's Syndrome. Presentation: Sunday, July 13, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.2099
Primary Topic
Sexual Differentiation and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SUN-168 Diagnosis of 46,XY Differences in Sex Development in a Patient with Adrenocortical Carcinoma

Carmen V. Villabona, Karla Baez, Alejandra Razzeto, Marie Louise Aoun et al.
Journal of the Endocrine Society
Sexual Differentiation and Disorders
article

SUN-168 Diagnosis of 46,XY Differences in Sex Development in a Patient with Adrenocortical Carcinoma

Carmen V. Villabona, Karla Baez, Alejandra Razzeto, Marie Louise Aoun, Isabella Blanco, Renato Rezende Savian
article en

Abstract

Abstract Disclosure: K. Baez: None. M. Aoun: None. I. Blanco: None. R.R. Savian: None. A. Razzeto: None. C.V. Villabona: None. 61-year-old patient with a history of adrenocortical carcinoma, leading to ACTH - independent Cushing syndrome s/p adrenalectomy, hypertension, fatty liver, hyperlipidemia, and asthma, presented for follow-up in the outpatient endocrinology clinic. The patient was incidentally found to have a large left adrenal mass in 2016 on a CT scan performed for symptoms of pyelonephritis. Laboratory evaluation revealed hypercortisolism and hyperandrogenemia with normal metanephrines and normetanephrines. The patient underwent left laparoscopic adrenalectomy in 2018, she was found to have an adrenocortical carcinoma. She underwent radiation therapy, and received mitotane treatment for two years along with hydrocortisone replacement therapy. She has primary adrenal insufficiency treated with hydrocortisone and fludrocortisone. The patient, on review of systems, reported a history of primary amenorrhea and delayed development of secondary sexual characteristics —absent terminal hair in the axilla and pubis. As a child she reported she had multiple tests and she underwent a surgical intervention to dilate the vaginal canal but she has been unaware of her condition. An evaluation in her teenage years revealed an absence of ovaries and uterus. The patient was started on estrogen replacement therapy, which she took late teen years until her early 20s. She reported difficulties having sexual intercourse. Additionally, on family history she reported her parents were first cousins and the patient has color blindness, this detail on her history ( X-linked recessive inheritance pattern disorder ) let us suspect she had a 46 XY karyotype. On laboratory tests, besides having adrenal insufficiency her estradiol and testosterone levels were low with high gonadotropins. Chromosomal analysis revealed a 46,XY karyotype without mosaicism, as we suspected. Conclusion: We report a rare case and first case described in the literature of a patient with gonadal dysgenesis with an adrenocortical carcinoma causing Cushing's Syndrome. Presentation: Sunday, July 13, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
University of Miami (US), Icesi University (CO)
Openalex Percentile: Top 73%
Sexual Differentiation and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.